Conversion From Tacrolimus (TAC) to Sirolimus (SLR)-Based Immunosuppression in Pediatric Liver Transplant Recipients: Indications and Efficacy

被引：0
|
作者：
Daniel, J. [1 ]
Fioravanti, V. [1 ]
Fischer, R. [1 ]
Hendrickson, R. [1 ]
Ricks, S. [1 ]
Davis, M. [1 ]
Andrews, W. [1 ]
机构：
[1] Univ Missouri, Childrens Mercy Hosp, Kansas City, MO 64108 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2014年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
A491
引用
收藏
页码：239 / 240
页数：2
相关论文
共 50 条
  • [1] Conversion From Tacrolimus (TAC) to Sirolimus (SLR)-Based Immunosuppression in Pediatric Liver Transplant Recipients: Indications and Efficacy
    Daniel, J.
    Fioravanti, V.
    Fischer, R.
    Hendrickson, R.
    Ricks, S.
    Davis, M.
    Andrews, W.
    TRANSPLANTATION, 2014, 98 : 239 - 240
  • [2] Indications and Efficacy of Converting From Tacrolimus (TAC) to Sirolimus (SLR)-Based Immunosuppression in Pediatric Patients Who Underwent Liver Transplantation for Unresectable Hepatoblastoma
    Hendrickson, R.
    Daniel, J.
    Andrews, W.
    Fischer, R.
    Manalang, M.
    Ricks, S.
    TRANSPLANTATION, 2014, 98 : 721 - 721
  • [3] Indications and Efficacy of Converting From Tacrolimus (TAC) to Sirolimus (SLR)-Based Immunosuppression in Pediatric Patients Who Underwent Liver Transplantation for Unresectable Hepatoblastoma.
    Hendrickson, R.
    Daniel, J.
    Andrews, W.
    Fischer, R.
    Manalang, M.
    Ricks, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 721 - 721
  • [4] Comparison of tacrolimus(TAC) and sirolimus(SLR) versus cyclosporine(CSA) and SLR in kidney transplant recipients maintained on steroid free immunosuppression.
    Saeed, MI
    Kumar, MSA
    Heifets, M
    Sierka, D
    Xiao, SG
    Moritz, MJ
    Parikh, MH
    Fyfe, B
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 218 - 218
  • [5] Evaluation of the Conversion from Tacrolimus to Sirolimus in Liver Transplant Recipients
    Bakhtiari, H.
    Todd, S.
    Snyder, H.
    Lo, D.
    Flynn, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 759 - 759
  • [6] A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients
    Yu, Si
    He, Xiaoshun
    Yang, Lu
    Ma, Yi
    Zhu, Xiaofeng
    Ju, Weiqiang
    Huang, Jiefu
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2008, 6 (02) : 113 - 117
  • [7] Use of sirolimus rescue therapy in pediatric liver transplant recipients with tacrolimus-based immunosuppression.
    Kato, T
    Pinna, AD
    Weppler, D
    Gonzalez, ML
    Mittal, N
    Khan, FA
    Nery, JR
    Tzakis, AG
    TRANSPLANTATION, 2000, 69 (08) : S165 - S165
  • [8] Indications and efficacy of conversion from tacrolimus- to sirolimus-based immunosuppression in pediatric patients who underwent liver transplantation for unresectable hepatoblastoma
    Hendrickson, Richard J.
    Sujka, Joseph
    Fischer, Ryan
    Manalang, Michelle
    Daniel, James
    Andrews, Walter S.
    PEDIATRIC TRANSPLANTATION, 2019, 23 (03)
  • [9] Conversion from Tacrolimus (TAC) to Sirolimus (SLR)-Based Immunosuppression in Pediatric Patients Who Underwent Liver Transplantation for Unresectable Hepatoblastoma-2 Year Follow-Up
    Hendrickson, R.
    Andrews, W.
    Davis, M.
    Cisneros, R.
    Fischer, R.
    Daniel, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 767 - 767
  • [10] IMMUNOREGULATORY EFFECTS OF CONVERSION FROM TACROLIMUS TO SIROLIMUS IN LIVER TRANSPLANT RECIPIENTS
    Levitsky, Josh
    Mathew, James M.
    Flaa, Catherine W.
    Rosen, Anne
    Tambur, Anat R.
    Miller, Joshua
    HEPATOLOGY, 2009, 50 (04) : 568A - 568A
12345